The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
about
Cytotoxic and targeted therapy for hereditary cancersImmune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?Tertiary Lymphoid Organs in Cancer TissuesThe Immunogenicity of Colorectal Cancer in Relation to Tumor Development and TreatmentMolecular Subtypes and Personalized Therapy in Metastatic Colorectal CancerCancer immunotherapy: the beginning of the end of cancer?Cytokine-Induced Modulation of Colorectal CancerPD-1/PD-L1 blockades in non-small-cell lung cancer therapyThe clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerNew therapeutic strategies for BRAF mutant colorectal cancersTargeted therapy for advanced gastric cancer: A review of current status and future prospectsAssociation of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancerImmune Checkpoint Modulation in Colorectal Cancer: What's New and What to ExpectFueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitorsExploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyImmune cell interplay in colorectal cancer prognosisCurrent and future molecular profiling of cancer by next-generation sequencingAntagonists of PD-1 and PD-L1 in Cancer TreatmentAdvances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockadeRationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.Opportunities for immunotherapy in microsatellite instable colorectal cancerRecent advances in understanding antitumor immunityMolecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future PerspectiveImmunological battlefield in gastric cancer and role of immunotherapiesCurrent debate in the oncologic management of rectal cancer.PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsValidation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationCurrent Status and Perspective of Immunotherapy in Gastrointestinal CancersThe role of immune checkpoint inhibition in the treatment of ovarian cancerRole of Deficient Mismatch Repair in the Personalized Management of Colorectal CancerImmune checkpoint blockade: a common denominator approach to cancer therapyGenetics and Genetic Biomarkers in Sporadic Colorectal CancerFrom mice to humans: developments in cancer immunoeditingPD-1 Blockade in Tumors with Mismatch-Repair DeficiencyA panoply of errors: polymerase proofreading domain mutations in cancerMolecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Lynch syndrome-related small intestinal adenocarcinomas.Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progressDissecting microsatellite instability in colorectal cancer: one size does not fit allPrognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancer
P2860
Q26739366-F9703C71-9130-4190-999E-8C4B5C8DD55EQ26742047-A11A0C5B-C50F-4195-AE5D-FB0B4631E9DBQ26742168-300F29EE-55EF-4D1F-9AB3-102F2C3C3069Q26745580-76035376-F257-4600-B22B-E689DBD41125Q26747329-D8414543-C079-4D98-8DAC-D7BDAE96F7B5Q26752277-7D33AF4F-63B9-4F80-909E-147EE975B3EAQ26752374-3800288A-8EB3-46D1-82AD-FE485EC10A4CQ26765024-4CF8854F-0083-425E-ACDD-F9092A72B8C7Q26766285-4A413A8C-AAF9-4A98-8EA2-AF6700CF3C91Q26772277-E3AF3003-B6D4-4EF6-AE8C-3CE54A54782EQ26774138-EDCA9971-E296-443A-BC15-D0AA7A249011Q26774690-69BC6322-A437-49CC-A140-9E5DE2FC1126Q26775578-11A72973-8C98-4863-A89B-8C0A341ECA72Q26778793-5B605599-599C-4054-9AC4-BE51B70B8A85Q26779184-4E90B7E5-60FA-4B6A-A5CC-34D877445AFFQ26781453-82A03610-1C7E-4980-BDBF-44C400B16855Q26796272-33690124-51CD-4D73-B394-CD120E2545EFQ26796311-5CA212D8-BD61-44F4-B007-565471F44210Q26801856-53ECACC8-98C3-44F9-993B-134E32216431Q27686800-15BEEAAB-AA02-4A41-9BC9-ECD4C8C6851CQ28066110-99B70A9C-C265-499D-9DFA-4E490E7BC22BQ28067217-95783091-E380-4B39-B8A2-4F76582AA4D2Q28070038-33B8C208-E65B-471A-8F3A-BE7AF998626FQ28071836-6CBF74C5-E57C-4D6E-B020-20BDC044DB6DQ28072948-72BD0A91-03BA-4E09-BD9C-4387C9089197Q28075712-0DC9793C-0EA8-4F24-A006-27E0005489E3Q28075719-250FB90C-E16E-4191-AC2E-1E94B84EB66CQ28076970-D4F033FD-8951-4984-9E29-6136841B51B9Q28077924-AA7413B7-E514-4830-9782-B129B31B1C27Q28080176-58275C84-EDF6-46BB-81AF-C46E43C93DCCQ28083981-F9F720F7-7D8B-4761-AE3C-D988807E6FDAQ28084346-14D0E078-015B-44D4-B6BA-EF5E990930BCQ28088304-48703A1E-06DC-4AB6-8560-17627BAB2CDEQ28262647-8C67ED91-1352-494E-A411-A5D25C4364C8Q28272700-54006466-7EBE-4786-9383-6F35CB87AB08Q30244608-416FF43D-6430-4BEA-883B-DC1EC65CCEA3Q33591577-8237EB5B-431C-4684-99DA-8E2B141ECE8AQ33593871-D593EB09-9DBA-4406-955E-C90291CA3E69Q33722794-A81A2541-EC4E-4F14-B434-09B6F575E394Q33738756-3CAA3757-3847-49F4-81DF-EA2E8B52E9C0
P2860
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@ast
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@en
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@nl
type
label
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@ast
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@en
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@nl
prefLabel
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@ast
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@en
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@nl
P2093
P2860
P50
P1433
P1476
The vigorous immune microenvir ...... ounter-inhibitory checkpoints.
@en
P2093
Brandon S Luber
Cynthia L Sears
Drew M Pardoll
Elizabeth C Wicks
Elizabeth M Hechenbleikner
Franck Housseau
Hongni Fan
Janis M Taube
P2860
P356
10.1158/2159-8290.CD-14-0863
P577
2014-10-30T00:00:00Z